Clinical Trial

Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease

Study acronym: AZITRATIM
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a randomized placebo-controlled trial in Crohn's disease patients before initiation of anti-tumor necrosis factor-α (anti-TNF) therapy that aims to test the effect of a pre-treatment short course of azithromycin therapy on immunogenicity
Protocol Amendment History 2 changes
notable Primary completion pushed: 2025-12-31 -> 2026-09-10 2026-07-30
minor Completion pushed: 2026-12-31 -> 2027-09-10 2026-07-30
Trial Details
NCT Number NCT05599347
Lead Sponsor Rambam Health Care Campus
Conditions Crohn's Disease Relapse, Biological Substance; Adverse Effect
Enrollment 180 participants
Start Date 2023-04-24
Primary Completion 2026-09-10 (estimated)
Study Completion 2027-09-10 (estimated)
Updated on ClinicalTrials.gov 2026-07-29